Skip to main content
. 2022 Mar 4;20:69. doi: 10.1186/s12957-021-02451-8

Table 2.

Subgroup analyses of the objective remission rate and one-year survival based on the Apatinib dose

Outcomes Subgroups Number of included RCTs Heterogeneity(I2) Model OR 95%CI P
Objective remission rat Apatinib dose≥600 mg/d 3 0% Fixed 2.44 1.97~2.81 <0.001
Apatinib dose<600 mg/d 10 0% Fixed 2.91 2.53~3.67 <0.001
One-year survival Apatinib dose≥600 mg/d 2 0% Fixed 2.69 2.04~2.89 <0.001
Apatinib dose<600 mg/d 5 16% Fixed 2.17 1.89~2.55 <0.001